Free Trial

This company has been marked as potentially delisted and may not be actively trading.

DowDuPont (DWDP) Financials

DowDuPont logo
Annual Income Statements for DowDuPont

Annual Income Statements for DowDuPont

This table shows DowDuPont's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
7,345 3,978 1,159 3,845 498 -2,951 6,467 5,868 423 703
Consolidated Net Income / (Loss)
7,783 4,404 1,291 4,000 600 -2,923 6,515 5,917 462 738
Net Income / (Loss) Continuing Operations
7,783 4,404 233 405 -124 -1,349 1,207 1,061 533 778
Total Pre-Tax Income
9,930 4,413 -1,525 600 -126 -1,259 1,444 1,448 504 1,192
Total Operating Income
5,486 4,456 -951 116 312 -1,387 1,739 1,674 747 1,574
Total Gross Profit
11,033 10,490 2,114 7,292 5,410 4,065 4,595 4,615 4,233 4,507
Total Revenue
48,778 48,158 11,672 22,594 15,436 11,128 12,566 13,017 12,068 12,386
Operating Revenue
48,778 48,158 11,672 22,594 15,436 11,128 12,566 13,017 12,068 12,386
Total Cost of Revenue
37,745 37,668 9,558 15,302 10,026 7,063 7,971 8,402 7,835 7,879
Operating Cost of Revenue
37,745 37,668 9,558 15,302 10,026 7,063 7,971 8,402 7,835 7,879
Total Operating Expenses
5,547 6,034 3,065 7,176 5,098 5,452 2,856 2,941 3,486 2,933
Selling, General & Admin Expense
2,948 2,953 1,615 3,028 2,057 1,492 1,602 1,467 1,408 1,552
Research & Development Expense
1,598 1,593 657 1,070 689 565 557 536 508 531
Amortization Expense
419 544 505 1,044 701 542 566 590 600 595
Impairment Charge
- - 0.00 0.00 242 1,862 0.00 0.00 804 0.00
Restructuring Charge
559 595 288 147 152 991 131 348 166 255
Total Other Income / (Expense), net
4,444 -43 -574 484 -438 128 -295 -226 -243 -382
Interest Expense
946 858 1,007 55 667 672 525 492 396 366
Interest & Investment Income
674 442 367 447 85 168 85 75 51 60
Other Income / (Expense), net
4,716 373 66 92 144 632 145 191 102 -76
Income Tax Expense
2,147 9.00 -1,758 195 -2.00 90 237 387 -29 414
Net Income / (Loss) Discontinued Operations
0.00 0.00 1,058 3,595 724 -1,574 5,308 4,856 -71 -40
Net Income / (Loss) Attributable to Noncontrolling Interest
98 86 132 155 102 28 48 49 39 35
Basic Earnings per Share
$6.45 $3.57 $2.18 $4.99 $0.67 ($4.01) $11.92 $11.77 $0.94 $1.68
Weighted Average Basic Shares Outstanding
1.13B 1.11B 526.60M 767M 746.30M 735.50M 542.70M 498.50M 449.90M 419.20M
Diluted Earnings per Share
$6.15 $3.52 $2.15 $4.96 $0.67 ($4.01) $11.89 $11.75 $0.94 $1.67
Weighted Average Diluted Shares Outstanding
1.24B 1.12B 532.70M 771.80M 746.30M 735.50M 544.20M 499.40M 451.20M 420.60M
Weighted Average Basic & Diluted Shares Outstanding
- 1.11B 2.33B 770.50M 739.39M 1.08B 512.91M 458.34M 417.58M 418.05M
Cash Dividends to Common per Share
$1.72 $1.84 $0.46 $0.38 $2.16 $1.20 $1.20 $1.32 $1.44 $1.52

Quarterly Income Statements for DowDuPont

This table shows DowDuPont's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders
367 4,226 257 -131 319 -22 189 178 454 -118 -589
Consolidated Net Income / (Loss)
376 4,238 265 -117 328 -14 197 185 462 -106 -582
Net Income / (Loss) Continuing Operations
359 105 273 269 291 -300 183 176 480 -61 -548
Total Pre-Tax Income
498 193 356 356 408 -616 267 296 586 43 -429
Total Operating Income
584 234 407 412 444 -516 313 459 460 342 -446
Total Gross Profit
1,222 1,056 1,035 1,064 1,104 1,030 1,013 1,175 1,194 1,125 1,146
Total Revenue
3,317 3,104 3,018 3,094 3,058 2,898 2,931 3,171 3,192 3,092 3,066
Operating Revenue
3,317 3,104 3,018 3,094 3,058 2,898 2,931 3,171 3,192 3,092 3,066
Total Cost of Revenue
2,095 2,048 1,983 2,030 1,954 1,868 1,918 1,996 1,998 1,967 1,920
Operating Cost of Revenue
2,095 2,048 1,983 2,030 1,954 1,868 1,918 1,996 1,998 1,967 1,920
Total Operating Expenses
638 822 628 652 660 1,546 700 716 734 783 1,592
Selling, General & Admin Expense
356 337 340 358 360 350 384 418 387 363 369
Research & Development Expense
129 123 127 125 128 128 125 134 134 138 137
Amortization Expense
146 143 147 146 155 152 149 151 149 146 146
Other Operating Expenses / (Income)
7.00 - 0.00 6.00 9.00 - 3.00 5.00 43 - 125
Impairment Charge
- - - - - - - - - - 768
Restructuring Charge
0.00 247 14 17 8.00 127 39 8.00 21 187 47
Total Other Income / (Expense), net
-86 -41 -51 -56 -36 -100 -46 -163 126 -299 17
Interest Expense
128 122 95 98 102 101 96 99 87 84 83
Interest & Investment Income
16 13 15 14 11 11 12 23 14 11 -1.00
Other Income / (Expense), net
26 68 29 28 55 -10 38 -87 199 -226 101
Income Tax Expense
139 88 83 87 117 -316 84 120 106 104 119
Net Income / (Loss) Discontinued Operations
17 4,133 -8.00 -386 37 286 14 9.00 -18 -45 -34
Net Income / (Loss) Attributable to Noncontrolling Interest
9.00 12 8.00 14 9.00 8.00 8.00 7.00 8.00 12 7.00
Basic Earnings per Share
$0.73 $8.53 $0.56 ($0.29) $0.71 ($0.04) $0.45 $0.43 $1.09 ($0.29) ($1.41)
Weighted Average Basic Shares Outstanding
499.40M 498.50M 458.80M 459.20M 451.70M 449.90M 422.80M 417.80M 417.90M 419.20M 418.50M
Diluted Earnings per Share
$0.73 $8.52 $0.56 ($0.28) $0.70 ($0.04) $0.45 $0.42 $1.08 ($0.28) ($1.41)
Weighted Average Diluted Shares Outstanding
500.40M 499.40M 460.20M 460.30M 453.40M 451.20M 424.30M 419.30M 419.50M 420.60M 418.50M
Weighted Average Basic & Diluted Shares Outstanding
496.79M 458.34M 459.02M 459.06M 430.04M 417.58M 418.10M 417.50M 417.96M 418.05M 418.50M
Cash Dividends to Common per Share
- - $0.36 $0.72 - - $0.38 $0.76 - - $0.41

Annual Cash Flow Statements for DowDuPont

This table details how cash moves in and out of DowDuPont's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
2,923 -1,879 878 2,012 -12,445 7,198 -6,699 1,696 -969 -911
Net Cash From Operating Activities
7,607 -2,957 878 5,503 1,409 4,095 1,846 1,249 2,191 2,321
Net Cash From Continuing Operating Activities
7,607 -2,957 878 5,503 1,409 4,095 1,846 1,249 2,191 2,321
Net Income / (Loss) Continuing Operations
7,783 4,404 1,291 4,000 600 -2,923 1,207 1,061 533 778
Consolidated Net Income / (Loss)
7,783 4,404 1,291 4,000 600 -2,923 6,515 5,917 462 738
Net Income / (Loss) Discontinued Operations
- - - - - - 5,308 4,856 -71 -40
Depreciation Expense
2,521 2,862 1,060 2,170 3,195 3,094 1,112 1,135 1,147 1,194
Non-Cash Adjustments To Reconcile Net Income
-3,187 23 0.00 0.00 2,109 3,448 -3.00 65 1,047 290
Changes in Operating Assets and Liabilities, net
490 -10,246 -1,473 -667 -4,748 476 -482 -1,012 -536 59
Net Cash From Investing Activities
-1,350 5,092 0.00 0.00 -2,313 -202 -2,298 9,004 172 -849
Net Cash From Continuing Investing Activities
-1,350 5,092 0.00 0.00 -2,313 -202 -2,298 9,004 172 -849
Purchase of Property, Plant & Equipment
-3,749 -3,917 0.00 0.00 -2,472 -1,194 -788 -662 -619 -579
Acquisitions
-926 -137 0.00 0.00 -180 -70 -2,346 5.00 -1,761 -321
Purchase of Investments
-1,246 -577 0.00 0.00 -197 -1.00 -2,001 -1,317 -32 0.00
Divestitures
3,911 306 0.00 0.00 299 1,033 797 10,951 1,244 8.00
Sale and/or Maturity of Investments
660 842 0.00 0.00 242 1.00 2,001 15 1,334 0.00
Other Investing Activities, net
0.00 8,575 0.00 0.00 -5.00 29 39 12 6.00 43
Net Cash From Financing Activities
-3,132 -4,014 0.00 -3,491 -11,550 3,238 -7,589 -7,646 -2,989 -1,847
Net Cash From Continuing Financing Activities
-3,132 -4,014 0.00 -3,491 -11,550 3,238 -7,589 -7,646 -2,989 -1,847
Repayment of Debt
-1,284 -623 0.00 0.00 -4,274 -3,915 -4,876 -3,254 -301 -688
Payment of Dividends
-2,540 -2,840 0.00 -3,491 -8,953 -932 -659 -678 -688 -661
Issuance of Debt
1,383 32 0.00 0.00 4,005 8,275 0.00 600 0.00 0.00
Issuance of Common Equity
525 398 0.00 0.00 85 57 115 88 27 50
Other Financing Activities, net
-50 -65 0.00 0.00 -84 -247 -2,169 -4,402 -2,027 -548
Effect of Exchange Rate Changes
-202 - - - 9.00 67 -72 -148 -37 -62
Other Net Changes in Cash
- - - - - - 1,414 -763 -306 -474
Cash Interest Paid
1,137 1,192 1,254 2,116 969 647 499 494 408 394
Cash Income Taxes Paid
1,405 1,592 1,368 2,199 722 495 561 844 394 316

Quarterly Cash Flow Statements for DowDuPont

This table details how cash moves in and out of DowDuPont's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents
405 1,838 -136 1,360 -3,249 1,056 -456 -838 177 206 -89
Net Cash From Operating Activities
578 185 405 400 740 646 493 527 737 564 382
Net Cash From Continuing Operating Activities
578 185 405 400 740 646 493 527 737 564 382
Net Income / (Loss) Continuing Operations
359 105 273 269 291 -300 183 176 480 -61 -548
Consolidated Net Income / (Loss)
376 4,238 265 -117 328 -14 197 185 462 -106 -582
Net Income / (Loss) Discontinued Operations
17 4,133 -8.00 -386 37 286 14 9.00 -18 -45 -34
Depreciation Expense
283 274 277 282 294 294 291 298 306 299 293
Non-Cash Adjustments To Reconcile Net Income
-25 81 14 38 12 983 33 101 -156 312 742
Changes in Operating Assets and Liabilities, net
-39 -275 -159 -189 143 -331 -14 -48 107 14 -105
Net Cash From Investing Activities
-78 9,133 -250 1,201 -1,870 1,091 -202 -100 -423 -124 -247
Net Cash From Continuing Investing Activities
-78 9,133 -250 1,201 -1,870 1,091 -202 -100 -423 -124 -247
Purchase of Property, Plant & Equipment
-155 -160 -232 -123 -119 -145 -207 -102 -109 -161 -249
Divestitures
64 10,587 0.00 - 16 1,228 5.00 - -12 15 0.00
Other Investing Activities, net
-7.00 8.00 -1.00 5.00 -6.00 8.00 0.00 10 10 23 2.00
Net Cash From Financing Activities
197 -7,185 -213 -164 -1,982 -630 -691 -840 -140 -176 -206
Net Cash From Continuing Financing Activities
197 -7,185 -213 -164 -1,982 -630 -691 -840 -140 -176 -206
Payment of Dividends
-177 -151 -199 -165 -165 -159 -179 -158 -163 -161 -194
Issuance of Common Equity
- 5.00 12 - 10 5.00 5.00 13 25 7.00 4.00
Other Financing Activities, net
-2.00 -4,377 -26 2.00 -2,001 -2.00 -517 -7.00 -2.00 -22 -16
Effect of Exchange Rate Changes
-113 43 -7.00 -22 -27 19 -25 -17 33 -53 13
Other Net Changes in Cash
-179 -338 -71 -55 -110 -70 -31 -408 -30 -5.00 -31

Annual Balance Sheets for DowDuPont

This table presents DowDuPont's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets
79,511 192,164 187,855 69,349 70,904 45,707 41,355 38,552 36,636
Total Current Assets
23,659 49,893 126,655 9,999 29,008 14,303 11,270 7,514 6,364
Cash & Equivalents
6,607 13,438 8,548 1,540 2,544 1,972 3,662 2,392 1,850
Restricted Cash
- - - - - - 7.00 411 6.00
Accounts Receivable
8,978 16,893 3,391 3,802 2,421 2,159 2,518 2,370 2,199
Inventories, net
7,363 16,992 4,107 4,319 2,393 2,086 2,329 2,147 2,130
Prepaid Expenses
- - - - 181 177 161 194 179
Plant, Property, & Equipment, net
23,486 36,247 9,917 10,143 6,867 5,753 5,731 5,884 5,768
Plant, Property & Equipment, gross
57,438 73,304 14,116 15,112 11,123 - 10,179 10,725 10,956
Accumulated Depreciation
33,952 37,057 4,199 4,969 4,256 - 4,448 4,841 5,188
Total Noncurrent Assets
32,366 106,024 51,283 49,207 35,029 25,651 24,354 25,154 24,504
Long-Term Investments
6,716 7,900 1,773 1,260 1,047 919 733 1,071 1,081
Goodwill
15,272 59,527 34,496 33,151 18,702 16,981 16,663 16,720 16,567
Intangible Assets
6,026 33,274 14,655 13,593 8,072 6,222 5,495 5,814 5,370
Noncurrent Deferred & Refundable Income Taxes
3,079 1,869 178 189 190 116 109 312 246
Other Noncurrent Operating Assets
565 2,774 134 1,014 812 1,360 1,251 1,237 1,204
Other Noncurrent Nonoperating Assets
- - - - 6,206 53 103 0.00 36
Total Liabilities & Shareholders' Equity
79,511 192,164 187,855 69,349 70,904 45,707 41,355 38,552 36,636
Total Liabilities
52,282 90,237 91,955 27,793 31,834 18,657 14,338 13,827 12,843
Total Current Liabilities
12,604 26,128 73,312 8,346 12,226 4,931 3,733 3,098 4,801
Short-Term Debt
907 4,015 15 3,830 1.00 150 300 0.00 1,848
Accounts Payable
6,616 12,861 2,619 2,934 2,222 2,102 2,103 1,675 1,720
Accrued Expenses
4,481 8,409 1,129 1,342 1,084 1,040 951 1,269 1,031
Current Deferred & Payable Income Tax Liabilities
600 843 115 240 169 201 233 154 202
Total Noncurrent Liabilities
39,678 64,109 18,643 19,447 19,608 13,726 10,605 10,729 8,042
Long-Term Debt
20,456 30,056 12,624 13,617 15,611 10,632 7,774 7,800 5,323
Noncurrent Deferred & Payable Income Tax Liabilities
923 6,266 3,912 3,467 2,053 1,459 1,158 1,130 915
Noncurrent Employee Benefit Liabilities
11,375 18,581 1,343 1,172 1,110 762 522 565 523
Other Noncurrent Operating Liabilities
5,560 7,969 764 1,191 834 873 1,151 1,234 1,281
Commitments & Contingencies
- - - - - - 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
27,229 101,927 95,900 41,556 39,070 27,050 27,017 24,725 23,793
Total Preferred & Common Equity
25,987 100,330 94,292 40,987 38,504 26,433 26,569 24,279 23,350
Total Common Equity
25,987 100,330 94,292 40,987 38,504 26,433 26,569 24,279 23,350
Common Stock
7,369 81,280 81,984 50,803 50,046 49,579 48,425 48,063 47,926
Retained Earnings
30,338 29,211 30,257 -8,400 -11,586 -23,187 -21,065 -22,874 -23,076
Accumulated Other Comprehensive Income / (Loss)
-9,822 -8,972 -12,394 -1,416 44 41 -791 -910 -1,500
Noncontrolling Interest
1,242 1,597 1,608 569 566 617 448 446 443

Quarterly Balance Sheets for DowDuPont

This table presents DowDuPont's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Total Assets
44,099 41,355 41,208 40,797 39,133 38,552 37,717 36,553 37,461 36,636 35,981
Total Current Assets
14,350 11,270 11,200 11,127 7,935 7,514 7,067 6,163 6,439 6,364 6,464
Cash & Equivalents
1,785 3,662 3,525 4,885 1,338 2,392 1,934 1,503 1,645 1,850 1,762
Restricted Cash
- 7.00 - 111 409 411 413 6.00 6.00 6.00 5.00
Accounts Receivable
2,257 2,518 2,438 2,315 2,399 2,370 2,365 2,313 2,363 2,199 2,291
Inventories, net
2,359 2,329 2,443 2,341 2,279 2,147 2,175 2,164 2,237 2,130 2,242
Prepaid Expenses
216 161 157 160 196 194 180 177 188 179 164
Plant, Property, & Equipment, net
5,477 5,731 5,738 5,701 5,756 5,884 5,772 5,699 5,784 5,768 5,780
Total Noncurrent Assets
24,272 24,354 24,270 23,969 25,442 25,154 24,878 24,691 25,238 24,504 23,737
Long-Term Investments
779 733 744 757 751 1,071 1,086 1,112 1,120 1,081 1,071
Goodwill
16,302 16,663 16,703 16,643 17,251 16,720 16,613 16,558 16,868 16,567 15,947
Intangible Assets
5,550 5,495 5,366 5,190 6,038 5,814 5,640 5,477 5,579 5,370 5,251
Noncurrent Deferred & Refundable Income Taxes
122 109 112 112 103 312 288 281 287 246 245
Other Noncurrent Operating Assets
1,416 1,251 1,241 1,267 1,299 1,237 1,251 1,263 1,349 1,204 1,187
Other Noncurrent Nonoperating Assets
103 103 104 0.00 0.00 0.00 - - 35 36 36
Total Liabilities & Shareholders' Equity
44,099 41,355 41,208 40,797 39,133 38,552 37,717 36,553 37,461 36,636 35,981
Total Liabilities
18,596 14,338 14,047 14,244 14,506 13,827 13,705 12,789 12,804 12,843 12,713
Total Current Liabilities
6,014 3,733 3,406 3,739 3,688 3,098 3,032 2,786 2,825 4,801 4,632
Short-Term Debt
1,287 300 300 300 475 0.00 - - - 1,848 1,849
Accounts Payable
2,061 2,103 1,921 1,768 1,685 1,675 1,624 1,655 1,702 1,720 1,657
Accrued Expenses
990 951 863 1,401 1,272 1,269 1,255 973 985 1,031 947
Current Deferred & Payable Income Tax Liabilities
284 233 186 135 119 154 153 158 138 202 179
Total Noncurrent Liabilities
12,582 10,605 10,641 10,505 10,818 10,729 10,673 10,003 9,979 8,042 8,081
Long-Term Debt
10,564 7,774 7,807 7,775 7,740 7,800 7,776 7,168 7,170 5,323 5,325
Noncurrent Deferred & Payable Income Tax Liabilities
464 1,158 1,145 1,028 1,326 1,130 1,098 1,045 1,027 915 897
Noncurrent Employee Benefit Liabilities
625 522 527 529 511 565 549 536 560 523 531
Other Noncurrent Operating Liabilities
929 1,151 1,162 1,173 1,241 1,234 1,250 1,254 1,222 1,281 1,328
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
25,503 27,017 27,161 26,553 24,627 24,725 24,012 23,764 24,657 23,793 23,268
Total Preferred & Common Equity
24,909 26,569 26,737 26,123 24,192 24,279 23,584 23,335 24,212 23,350 22,834
Total Common Equity
24,909 26,569 26,737 26,123 24,192 24,279 23,584 23,335 24,212 23,350 22,834
Common Stock
49,204 48,425 48,261 47,951 48,194 48,063 48,242 48,023 48,063 47,926 47,762
Retained Earnings
-22,692 -21,065 -20,807 -20,938 -22,854 -22,874 -23,519 -23,414 -22,959 -23,076 -23,665
Accumulated Other Comprehensive Income / (Loss)
-1,603 -791 -717 -890 -1,148 -910 -1,139 -1,274 -892 -1,500 -1,263
Noncontrolling Interest
594 448 424 430 435 446 428 429 445 443 434

Annual Metrics and Ratios for DowDuPont

This table displays calculated financial ratios and metrics derived from DowDuPont's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
0.00% -1.27% -75.76% 93.57% -31.68% -27.91% 12.92% 3.59% -7.29% 2.64%
EBITDA Growth
0.00% -39.55% -97.72% 1,258.86% 64.17% -40.09% 28.60% -0.27% -33.47% 34.87%
EBIT Growth
0.00% -52.67% -118.33% 123.50% 119.23% -265.57% 349.54% -1.01% -54.48% 76.44%
NOPAT Growth
0.00% 3.42% -114.97% 111.76% 178.93% -544.55% 249.71% -15.62% -35.60% 30.04%
Net Income Growth
0.00% -43.42% -70.69% 209.84% -85.00% -587.17% 322.89% -9.18% -92.19% 59.74%
EPS Growth
0.00% -42.76% -70.69% 209.84% -86.49% -698.51% 396.51% -1.18% -92.00% 77.66%
Operating Cash Flow Growth
0.00% -138.87% 129.69% 526.77% -74.40% 190.63% -54.92% -32.34% 75.42% 5.93%
Free Cash Flow Firm Growth
0.00% 0.00% -156.64% 171.34% -97.58% 1,542.67% -74.76% -69.49% -83.88% 506.99%
Invested Capital Growth
0.00% 0.00% 222.39% -49.56% -2.00% -41.58% -12.79% -1.74% 1.82% -2.30%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 880.64% 163.77% 14.53% 27.44% -1.08% -1.68% 1.59%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 149.42% 1,509.39% 322.55% -13.79% 7.57% -28.82% 31.64%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 107.11% 118.64% 50.46% -38.51% -2.36% -49.37% 75.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 105.53% 109.23% 35.64% -49.27% -9.62% -26.13% 41.88%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 102.63% -34.85% 1.42% -0.06% 210.60% -90.20% -11.08%
EPS Q/Q Growth
0.00% 0.00% 0.00% 102.63% -36.79% 1.72% -4.42% 157.11% -90.11% -12.57%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 109.55% -20.01% -60.97% 222.94% -79.28% -0.08% 26.65% -3.41%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% -97.79% 1,015.81% -76.80% -78.79% 11.89% 93.93%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -52.07% 0.93% -42.01% -18.46% -0.73% -1.77% -3.55%
Profitability Metrics
- - - - - - - - - -
Gross Margin
22.62% 21.78% 18.11% 32.27% 35.05% 36.53% 36.57% 35.45% 35.08% 36.39%
EBITDA Margin
26.08% 15.97% 1.50% 10.52% 25.29% 21.02% 23.94% 23.05% 16.54% 21.73%
Operating Margin
11.25% 9.25% -8.15% 0.51% 2.02% -12.46% 13.84% 12.86% 6.19% 12.71%
EBIT Margin
20.92% 10.03% -7.58% 0.92% 2.95% -6.78% 14.99% 14.33% 7.04% 12.09%
Profit (Net Income) Margin
15.96% 9.14% 11.06% 17.70% 3.89% -26.27% 51.85% 45.46% 3.83% 5.96%
Tax Burden Percent
78.38% 99.80% -84.66% 666.67% -476.19% 232.17% 451.18% 408.63% 91.67% 61.91%
Interest Burden Percent
97.33% 91.39% 172.32% 288.46% -27.63% 166.76% 76.65% 77.64% 59.36% 79.57%
Effective Tax Rate
21.62% 0.20% 0.00% 32.50% 0.00% 0.00% 16.41% 26.73% -5.75% 34.73%
Return on Invested Capital (ROIC)
0.00% 25.22% -0.89% 0.09% 0.38% -2.18% 4.73% 4.32% 2.78% 3.63%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 24.15% 18.85% -29.20% -2.81% -48.59% -213.11% 350.60% -10.21% -3.50%
Return on Net Nonoperating Assets (RNNOA)
0.00% 7.13% 2.89% 3.95% 0.49% -5.07% 14.98% 17.57% -1.00% -0.59%
Return on Equity (ROE)
0.00% 32.35% 2.00% 4.04% 0.87% -7.25% 19.71% 21.89% 1.79% 3.04%
Cash Return on Invested Capital (CROIC)
0.00% -174.78% -106.19% 65.99% 2.40% 50.31% 18.39% 6.08% 0.98% 5.96%
Operating Return on Assets (OROA)
0.00% 6.07% -0.65% 0.11% 0.35% -1.08% 3.23% 4.28% 2.13% 3.98%
Return on Assets (ROA)
0.00% 5.54% 0.95% 2.11% 0.47% -4.17% 11.17% 13.59% 1.16% 1.96%
Return on Common Equity (ROCE)
0.00% 30.87% 1.96% 3.98% 0.86% -7.15% 19.35% 21.46% 1.75% 2.99%
Return on Equity Simple (ROE_SIMPLE)
0.00% 16.95% 1.29% 4.24% 1.46% -7.59% 24.65% 22.27% 1.90% 3.16%
Net Operating Profit after Tax (NOPAT)
4,300 4,447 -666 78 218 -971 1,454 1,227 790 1,027
NOPAT Margin
8.82% 9.23% -5.70% 0.35% 1.41% -8.72% 11.57% 9.42% 6.55% 8.29%
Net Nonoperating Expense Percent (NNEP)
0.00% 1.07% -19.75% 29.29% 3.19% 46.41% 217.84% -346.28% 12.99% 7.12%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 3.50% 2.43% 3.32%
Cost of Revenue to Revenue
77.38% 78.22% 81.89% 67.73% 64.95% 63.47% 63.43% 64.55% 64.92% 63.61%
SG&A Expenses to Revenue
6.04% 6.13% 13.84% 13.40% 13.33% 13.41% 12.75% 11.27% 11.67% 12.53%
R&D to Revenue
3.28% 3.31% 5.63% 4.74% 4.46% 5.08% 4.43% 4.12% 4.21% 4.29%
Operating Expenses to Revenue
11.37% 12.53% 26.26% 31.76% 33.03% 48.99% 22.73% 22.59% 28.89% 23.68%
Earnings before Interest and Taxes (EBIT)
10,202 4,829 -885 208 456 -755 1,884 1,865 849 1,498
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
12,723 7,691 175 2,378 3,904 2,339 3,008 3,000 1,996 2,692
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 1.45 1.16 1.06 1.27 1.51 1.23 1.34 1.36
Price to Tangible Book Value (P/TBV)
0.00 0.00 19.36 2.43 0.00 4.17 12.33 7.43 18.60 22.55
Price to Revenue (P/Rev)
0.00 0.00 12.49 4.86 2.82 4.39 3.17 2.52 2.69 2.57
Price to Earnings (P/E)
0.00 0.00 125.73 28.56 87.45 0.00 6.16 5.59 76.72 45.33
Dividend Yield
0.00% 0.00% 0.61% 3.18% 1.66% 1.80% 1.56% 2.00% 1.91% 1.99%
Earnings Yield
0.00% 0.00% 0.80% 3.50% 1.14% 0.00% 16.24% 17.90% 1.30% 2.21%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 1.40 1.98 1.05 1.87 1.69 1.27 1.29 1.31
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 13.63 5.03 3.81 5.52 3.85 2.74 3.05 2.95
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 909.14 47.81 15.05 26.28 16.07 11.87 18.45 13.58
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 546.60 128.87 0.00 25.65 19.09 43.37 24.40
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 1,452.01 269.07 0.00 33.25 29.02 46.61 35.57
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 181.21 20.66 41.71 15.01 26.18 28.50 16.81 15.75
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 2.01 43.10 2.74 8.55 20.64 132.47 21.66
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 0.78 0.33 0.13 0.42 0.40 0.40 0.30 0.32 0.30
Long-Term Debt to Equity
0.00 0.75 0.29 0.13 0.33 0.40 0.39 0.29 0.32 0.22
Financial Leverage
0.00 0.30 0.15 -0.14 -0.17 0.10 -0.07 0.05 0.10 0.17
Leverage Ratio
0.00 2.92 2.10 1.92 1.87 1.74 1.76 1.61 1.54 1.55
Compound Leverage Factor
0.00 2.67 3.62 5.54 -0.52 2.90 1.35 1.25 0.92 1.23
Debt to Total Capital
0.00% 43.96% 25.05% 11.64% 29.57% 28.55% 28.50% 23.01% 23.98% 23.16%
Short-Term Debt to Total Capital
0.00% 1.87% 2.95% 0.01% 6.49% 0.00% 0.40% 0.85% 0.00% 5.97%
Long-Term Debt to Total Capital
0.00% 42.10% 22.10% 11.63% 23.08% 28.55% 28.10% 22.15% 23.98% 17.19%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 2.56% 1.17% 1.48% 0.96% 1.04% 1.63% 1.28% 1.37% 1.43%
Common Equity to Total Capital
0.00% 53.48% 73.77% 86.87% 69.47% 70.41% 69.87% 75.71% 74.65% 75.41%
Debt to EBITDA
0.00 2.78 194.69 5.32 4.47 6.67 3.58 2.69 3.91 2.66
Net Debt to EBITDA
0.00 1.05 67.30 0.96 3.75 5.14 2.62 0.79 1.97 1.57
Long-Term Debt to EBITDA
0.00 2.66 171.75 5.31 3.49 6.67 3.53 2.59 3.91 1.98
Debt to NOPAT
0.00 4.80 -51.18 161.42 79.89 -16.08 7.42 6.58 9.87 6.98
Net Debt to NOPAT
0.00 1.81 -17.69 29.23 67.07 -12.38 5.43 1.93 4.97 4.12
Long-Term Debt to NOPAT
0.00 4.60 -45.15 161.23 62.35 -16.08 7.31 6.34 9.87 5.18
Altman Z-Score
0.00 0.00 1.38 1.41 1.04 1.10 1.23 1.34 1.10 1.13
Noncontrolling Interest Sharing Ratio
0.00% 4.56% 2.20% 1.62% 1.58% 1.41% 1.79% 1.97% 1.73% 1.83%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
0.00 1.88 1.91 1.73 1.20 2.37 2.90 3.02 2.43 1.33
Quick Ratio
0.00 1.24 1.20 0.16 0.64 0.41 0.84 2.00 1.54 0.84
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -30,822 -79,101 56,434 1,363 22,396 5,653 1,725 278 1,687
Operating Cash Flow to CapEx
202.91% -75.49% 0.00% 0.00% 57.00% 342.96% 234.26% 188.67% 353.96% 400.86%
Free Cash Flow to Firm to Interest Expense
0.00 -35.92 -78.55 1,026.08 2.04 33.33 10.77 3.51 0.70 4.61
Operating Cash Flow to Interest Expense
8.04 -3.45 0.87 100.05 2.11 6.09 3.52 2.54 5.53 6.34
Operating Cash Flow Less CapEx to Interest Expense
4.08 -8.01 0.87 100.05 -1.59 4.32 2.02 1.19 3.97 4.76
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.00 0.61 0.09 0.12 0.12 0.16 0.22 0.30 0.30 0.33
Accounts Receivable Turnover
0.00 5.36 0.90 2.23 4.29 3.58 5.49 5.57 4.94 5.42
Inventory Turnover
0.00 5.12 0.78 1.45 2.38 2.10 3.56 3.81 3.50 3.68
Fixed Asset Turnover
0.00 2.05 0.39 0.98 1.54 1.31 1.99 2.27 2.08 2.13
Accounts Payable Turnover
0.00 5.69 0.98 1.98 3.61 2.74 3.69 4.00 4.15 4.64
Days Sales Outstanding (DSO)
0.00 68.05 404.51 163.84 85.04 102.06 66.52 65.57 73.92 67.32
Days Inventory Outstanding (DIO)
0.00 71.35 465.03 251.64 153.38 173.43 102.55 95.90 104.26 99.07
Days Payable Outstanding (DPO)
0.00 64.11 371.89 184.62 101.08 133.23 99.00 91.34 88.00 78.64
Cash Conversion Cycle (CCC)
0.00 75.28 497.65 230.86 137.34 142.26 70.07 70.13 90.18 87.75
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
0.00 35,269 113,704 57,348 56,203 32,836 28,637 28,139 28,651 27,991
Invested Capital Turnover
0.00 2.73 0.16 0.26 0.27 0.25 0.41 0.46 0.43 0.44
Increase / (Decrease) in Invested Capital
0.00 35,269 78,435 -56,356 -1,145 -23,367 -4,199 -498 512 -660
Enterprise Value (EV)
0.00 0.00 159,100 113,693 58,765 61,457 48,329 35,601 36,825 36,546
Market Capitalization
0.00 0.00 145,726 109,796 43,549 48,870 39,821 32,783 32,453 31,869
Book Value per Share
$0.00 $23.45 $42.88 $41.10 $55.33 $52.47 $51.02 $53.48 $56.46 $55.87
Tangible Book Value per Share
$0.00 $4.23 $3.22 $19.68 ($7.77) $15.98 $6.23 $8.88 $4.06 $3.38
Total Capital
0.00 48,592 135,998 108,539 59,003 54,682 37,832 35,091 32,525 30,964
Total Debt
0.00 21,363 34,071 12,639 17,447 15,612 10,782 8,074 7,800 7,171
Total Long-Term Debt
0.00 20,456 30,056 12,624 13,617 15,611 10,632 7,774 7,800 5,323
Net Debt
0.00 8,040 11,777 2,289 14,647 12,021 7,891 2,370 3,926 4,234
Capital Expenditures (CapEx)
3,749 3,917 0.00 0.00 2,472 1,194 788 662 619 579
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 5,355 13,386 44,781 3,943 14,239 7,550 2,866 1,613 1,555
Debt-free Net Working Capital (DFNWC)
0.00 11,962 27,780 53,358 5,483 16,783 9,522 7,837 4,416 3,411
Net Working Capital (NWC)
0.00 11,055 23,765 53,343 1,653 16,782 9,372 7,537 4,416 1,563
Net Nonoperating Expense (NNE)
-3,483 43 -1,957 -3,922 -382 1,952 -5,061 -4,690 328 289
Net Nonoperating Obligations (NNO)
0.00 8,040 11,777 -38,552 14,647 -6,234 1,587 1,122 3,926 4,198
Total Depreciation and Amortization (D&A)
2,521 2,862 1,060 2,170 3,448 3,094 1,124 1,135 1,147 1,194
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 11.12% 114.68% 198.20% 25.54% 127.96% 60.08% 22.02% 13.37% 12.55%
Debt-free Net Working Capital to Revenue
0.00% 24.84% 238.01% 236.16% 35.52% 150.82% 75.78% 60.21% 36.59% 27.54%
Net Working Capital to Revenue
0.00% 22.96% 203.61% 236.09% 10.71% 150.81% 74.58% 57.90% 36.59% 12.62%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.43 $0.78 $0.67 ($4.01) $11.92 $11.77 $0.94 $1.68
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 3.36B 4.89B 746.30M 735.50M 542.70M 498.50M 449.90M 419.20M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.43 $0.78 $0.67 ($4.01) $11.89 $11.75 $0.94 $1.67
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 3.40B 4.92B 746.30M 735.50M 544.20M 499.40M 451.20M 420.60M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.67 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 4.95B 4.79B 739.39M 1.08B 512.91M 458.34M 417.58M 418.05M
Normalized Net Operating Profit after Tax (NOPAT)
4,738 5,041 -464 178 494 1,026 1,563 1,482 1,202 1,194
Normalized NOPAT Margin
9.71% 10.47% -3.98% 0.79% 3.20% 9.22% 12.44% 11.38% 9.96% 9.64%
Pre Tax Income Margin
20.36% 9.16% -13.07% 2.66% -0.82% -11.31% 11.49% 11.12% 4.18% 9.62%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
10.78 5.63 -0.88 3.78 0.68 -1.12 3.59 3.79 2.14 4.09
NOPAT to Interest Expense
4.55 5.18 -0.66 1.42 0.33 -1.44 2.77 2.49 1.99 2.81
EBIT Less CapEx to Interest Expense
6.82 1.06 -0.88 3.78 -3.02 -2.90 2.09 2.45 0.58 2.51
NOPAT Less CapEx to Interest Expense
0.58 0.62 -0.66 1.42 -3.38 -3.22 1.27 1.15 0.43 1.22
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
32.64% 64.49% 0.00% 87.28% 1,492.17% -31.89% 10.12% 11.46% 148.92% 89.57%
Augmented Payout Ratio
47.62% 85.29% 0.00% 87.28% 1,880.33% -31.89% 10.12% 11.46% 148.92% 89.57%

Quarterly Metrics and Ratios for DowDuPont

This table displays calculated financial ratios and metrics derived from DowDuPont's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
3.69% -4.37% -7.82% -6.86% -7.81% -6.64% -2.88% 2.49% 4.38% 6.69% 4.61%
EBITDA Growth
11.35% 57.81% -0.28% -11.52% -11.20% -140.28% -9.96% -7.20% 21.69% 278.88% -108.10%
EBIT Growth
41.20% -12.97% 16.89% -24.14% -18.20% -274.17% -19.50% -15.45% 32.06% 122.05% -198.29%
NOPAT Growth
27.85% -50.46% 1.44% -16.11% -24.78% -383.73% -31.27% -12.33% 18.98% -34.32% -245.53%
Net Income Growth
-6.93% 1,775.22% -47.83% -114.72% -12.77% -100.33% -25.66% 258.12% 40.85% -657.14% -395.43%
EPS Growth
-2.67% 535.82% -41.05% -118.06% -4.11% -100.47% -19.64% 250.00% 54.29% -600.00% -413.33%
Operating Cash Flow Growth
-31.35% -0.54% 93.78% 44.40% 28.03% 249.19% 21.73% 31.75% -0.41% -12.69% -22.52%
Free Cash Flow Firm Growth
-67.05% -85.97% -82.47% -72.72% -107.01% -239.64% -66.73% -126.47% 203.66% 120.02% 87.28%
Invested Capital Growth
-19.29% -1.74% -1.56% -3.43% 2.90% 1.82% -0.14% 2.22% -0.50% -2.30% -2.78%
Revenue Q/Q Growth
-0.15% -6.42% -2.77% 2.52% -1.16% -5.23% 1.14% 8.19% 0.66% -3.13% -0.84%
EBITDA Q/Q Growth
9.44% -35.50% 23.78% 1.26% 9.83% -129.26% 376.72% 4.36% 44.03% -56.99% -112.53%
EBIT Q/Q Growth
5.17% -50.49% 44.37% 0.92% 13.41% -205.41% 166.73% 5.98% 77.15% -82.40% -397.41%
NOPAT Q/Q Growth
13.44% -69.76% 145.17% -0.25% 1.72% -214.06% 159.39% 27.22% 38.06% -228.76% 35.65%
Net Income Q/Q Growth
-52.70% 1,027.13% -93.75% -144.15% 380.34% -104.27% 1,507.14% -6.09% 149.73% -122.94% -449.06%
EPS Q/Q Growth
-52.90% 1,067.12% -93.43% -150.00% 350.00% -105.71% 1,225.00% -6.67% 157.14% -125.93% -403.57%
Operating Cash Flow Q/Q Growth
108.66% -67.99% 118.92% -1.23% 85.00% -12.70% -23.68% 6.90% 39.85% -23.47% -32.27%
Free Cash Flow Firm Q/Q Growth
51.39% -91.31% 21.88% 70.10% -138.90% -73.14% 129.03% -235.32% 252.38% -66.56% 171.57%
Invested Capital Q/Q Growth
-1.16% -0.73% 0.91% -2.46% 5.32% -1.77% -1.03% -0.16% 2.51% -3.55% -1.51%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
36.84% 34.02% 34.29% 34.39% 36.10% 35.54% 34.56% 37.05% 37.41% 36.38% 37.38%
EBITDA Margin
26.92% 18.56% 23.62% 23.34% 25.93% -8.01% 21.90% 21.13% 30.23% 13.42% -1.70%
Operating Margin
17.61% 7.54% 13.49% 13.32% 14.52% -17.81% 10.68% 14.47% 14.41% 11.06% -14.55%
EBIT Margin
18.39% 9.73% 14.45% 14.22% 16.32% -18.15% 11.98% 11.73% 20.65% 3.75% -11.25%
Profit (Net Income) Margin
11.34% 136.53% 8.78% -3.78% 10.73% -0.48% 6.72% 5.83% 14.47% -3.43% -18.98%
Tax Burden Percent
75.50% 2,195.85% 74.44% -32.87% 80.39% 2.27% 73.78% 62.50% 78.84% -246.51% 135.66%
Interest Burden Percent
81.64% 63.91% 81.65% 80.91% 81.76% 117.11% 76.07% 79.57% 88.92% 37.07% 124.35%
Effective Tax Rate
27.91% 45.60% 23.31% 24.44% 28.68% 0.00% 31.46% 40.54% 18.09% 241.86% 0.00%
Return on Invested Capital (ROIC)
5.26% 1.88% 4.61% 4.47% 4.42% -5.30% 3.09% 3.71% 4.95% -6.86% -4.56%
ROIC Less NNEP Spread (ROIC-NNEP)
4.42% 305.36% 1.74% -18.77% 4.73% 8.46% 2.46% 0.62% 6.86% 2.47% -10.80%
Return on Net Nonoperating Assets (RNNOA)
0.90% 15.30% 0.11% -1.31% 0.70% 0.83% 0.27% 0.07% 1.24% 0.41% -1.97%
Return on Equity (ROE)
6.16% 17.18% 4.72% 3.16% 5.12% -4.47% 3.36% 3.78% 6.19% -6.45% -6.53%
Cash Return on Invested Capital (CROIC)
25.62% 6.08% 5.89% 7.66% 0.86% 0.98% 2.59% 0.26% 2.99% 5.96% 3.09%
Operating Return on Assets (OROA)
5.37% 2.91% 4.26% 4.18% 4.81% -5.48% 3.64% 3.66% 6.57% 1.24% -3.82%
Return on Assets (ROA)
3.31% 40.83% 2.59% -1.11% 3.16% -0.15% 2.04% 1.82% 4.61% -1.13% -6.45%
Return on Common Equity (ROCE)
6.02% 16.84% 4.63% 3.10% 5.01% -4.39% 3.30% 3.71% 6.08% -6.33% -6.42%
Return on Equity Simple (ROE_SIMPLE)
7.65% 0.00% 21.22% 18.23% 19.49% 0.00% 1.67% 2.98% 3.43% 0.00% -0.18%
Net Operating Profit after Tax (NOPAT)
421 127 312 311 317 -361 215 273 377 -485 -312
NOPAT Margin
12.69% 4.10% 10.34% 10.06% 10.36% -12.46% 7.32% 8.61% 11.80% -15.69% -10.18%
Net Nonoperating Expense Percent (NNEP)
0.84% -303.48% 2.87% 23.25% -0.31% -13.76% 0.63% 3.09% -1.91% -9.33% 6.24%
Return On Investment Capital (ROIC_SIMPLE)
- 0.36% - - - -1.11% - - - -1.57% -1.03%
Cost of Revenue to Revenue
63.16% 65.98% 65.71% 65.61% 63.90% 64.46% 65.44% 62.95% 62.59% 63.62% 62.62%
SG&A Expenses to Revenue
10.73% 10.86% 11.27% 11.57% 11.77% 12.08% 13.10% 13.18% 12.12% 11.74% 12.04%
R&D to Revenue
3.89% 3.96% 4.21% 4.04% 4.19% 4.42% 4.26% 4.23% 4.20% 4.46% 4.47%
Operating Expenses to Revenue
19.23% 26.48% 20.81% 21.07% 21.58% 53.35% 23.88% 22.58% 23.00% 25.32% 51.92%
Earnings before Interest and Taxes (EBIT)
610 302 436 440 499 -526 351 372 659 116 -345
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
893 576 713 722 793 -232 642 670 965 415 -52
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.98 1.23 1.20 1.23 1.39 1.34 1.39 1.44 1.54 1.36 1.37
Price to Tangible Book Value (P/TBV)
7.98 7.43 6.87 7.49 37.18 18.60 24.66 25.89 21.08 22.55 19.08
Price to Revenue (P/Rev)
1.85 2.52 2.51 2.57 2.74 2.69 2.74 2.79 3.05 2.57 2.49
Price to Earnings (P/E)
13.21 5.59 5.69 6.81 7.19 76.72 92.45 50.68 46.56 45.33 0.00
Dividend Yield
2.65% 2.00% 1.93% 1.97% 1.93% 1.91% 1.91% 1.84% 1.68% 1.99% 2.08%
Earnings Yield
7.57% 17.90% 17.57% 14.68% 13.91% 1.30% 1.08% 1.97% 2.15% 2.21% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.21 1.27 1.23 1.26 1.36 1.29 1.33 1.36 1.45 1.31 1.31
Enterprise Value to Revenue (EV/Rev)
2.60 2.74 2.74 2.78 3.24 3.05 3.14 3.20 3.45 2.95 2.87
Enterprise Value to EBITDA (EV/EBITDA)
12.28 11.87 11.68 12.02 14.17 18.45 19.53 20.62 20.56 13.58 18.01
Enterprise Value to EBIT (EV/EBIT)
17.94 19.09 18.16 19.52 23.69 43.37 49.20 55.50 49.12 24.40 44.88
Enterprise Value to NOPAT (EV/NOPAT)
25.25 29.02 28.32 29.73 37.14 46.61 53.93 55.97 58.07 35.57 466.02
Enterprise Value to Operating Cash Flow (EV/OCF)
27.41 28.50 24.24 22.26 22.96 16.81 16.49 16.06 17.50 15.75 16.29
Enterprise Value to Free Cash Flow (EV/FCFF)
4.21 20.64 20.77 16.17 159.89 132.47 51.07 521.02 48.33 21.66 41.64
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.46 0.30 0.30 0.30 0.33 0.32 0.32 0.30 0.29 0.30 0.31
Long-Term Debt to Equity
0.41 0.29 0.29 0.29 0.31 0.32 0.32 0.30 0.29 0.22 0.23
Financial Leverage
0.20 0.05 0.06 0.07 0.15 0.10 0.11 0.11 0.18 0.17 0.18
Leverage Ratio
1.71 1.61 1.61 1.62 1.66 1.54 1.54 1.54 1.55 1.55 1.56
Compound Leverage Factor
1.39 1.03 1.31 1.31 1.36 1.81 1.17 1.22 1.38 0.57 1.94
Debt to Total Capital
31.73% 23.01% 22.99% 23.32% 25.01% 23.98% 24.46% 23.17% 22.53% 23.16% 23.57%
Short-Term Debt to Total Capital
3.45% 0.85% 0.85% 0.87% 1.45% 0.00% 0.00% 0.00% 0.00% 5.97% 6.07%
Long-Term Debt to Total Capital
28.28% 22.15% 22.14% 22.45% 23.57% 23.98% 24.46% 23.17% 22.53% 17.19% 17.49%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.59% 1.28% 1.20% 1.24% 1.32% 1.37% 1.35% 1.39% 1.40% 1.43% 1.43%
Common Equity to Total Capital
66.68% 75.71% 75.81% 75.44% 73.66% 74.65% 74.19% 75.44% 76.07% 75.41% 75.01%
Debt to EBITDA
4.25 2.69 2.70 2.78 2.93 3.91 4.04 3.83 3.51 2.66 3.59
Net Debt to EBITDA
3.33 0.79 0.84 0.80 2.04 1.97 2.26 2.43 2.15 1.57 2.17
Long-Term Debt to EBITDA
3.79 2.59 2.60 2.68 2.76 3.91 4.04 3.83 3.51 1.98 2.67
Debt to NOPAT
8.73 6.58 6.56 6.88 7.68 9.87 11.16 10.39 9.90 6.98 92.89
Net Debt to NOPAT
6.84 1.93 2.04 1.98 5.35 4.97 6.23 6.59 6.08 4.12 56.15
Long-Term Debt to NOPAT
7.78 6.34 6.31 6.62 7.24 9.87 11.16 10.39 9.90 5.18 68.95
Altman Z-Score
0.64 1.22 1.23 1.20 1.06 0.98 1.04 1.16 1.38 1.01 0.93
Noncontrolling Interest Sharing Ratio
2.28% 1.97% 1.93% 1.97% 2.05% 1.73% 1.66% 1.71% 1.79% 1.83% 1.82%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.39 3.02 3.29 2.98 2.15 2.43 2.33 2.21 2.28 1.33 1.40
Quick Ratio
0.67 2.00 2.14 1.93 1.01 1.54 1.42 1.37 1.42 0.84 0.88
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
7,194 625 762 1,296 -504 -873 254 -343 523 175 475
Operating Cash Flow to CapEx
372.90% 115.63% 174.57% 325.20% 621.85% 445.52% 238.16% 516.67% 676.15% 350.31% 153.41%
Free Cash Flow to Firm to Interest Expense
56.20 5.13 8.02 13.23 -4.94 -8.65 2.64 -3.47 6.01 2.08 5.72
Operating Cash Flow to Interest Expense
4.52 1.52 4.26 4.08 7.25 6.40 5.14 5.32 8.47 6.71 4.60
Operating Cash Flow Less CapEx to Interest Expense
3.30 0.20 1.82 2.83 6.09 4.96 2.98 4.29 7.22 4.80 1.60
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.29 0.30 0.29 0.29 0.29 0.30 0.30 0.31 0.32 0.33 0.34
Accounts Receivable Turnover
5.10 5.57 5.36 5.47 5.27 4.94 4.99 5.21 5.12 5.42 5.38
Inventory Turnover
3.26 3.81 3.54 3.47 3.46 3.50 3.37 3.43 3.45 3.68 3.57
Fixed Asset Turnover
2.12 2.27 2.24 2.23 2.19 2.08 2.08 2.12 2.11 2.13 2.17
Accounts Payable Turnover
3.68 4.00 4.04 4.18 4.28 4.15 4.38 4.52 4.59 4.64 4.80
Days Sales Outstanding (DSO)
71.63 65.57 68.15 66.72 69.23 73.92 73.16 70.05 71.28 67.32 67.86
Days Inventory Outstanding (DIO)
112.07 95.90 103.24 105.10 105.61 104.26 108.47 106.28 105.93 99.07 102.28
Days Payable Outstanding (DPO)
99.06 91.34 90.36 87.33 85.30 88.00 83.26 80.75 79.45 78.64 75.98
Cash Conversion Cycle (CCC)
84.64 70.13 81.03 84.49 89.54 90.18 98.36 95.57 97.77 87.75 94.17
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
28,346 28,139 28,394 27,695 29,167 28,651 28,355 28,311 29,021 27,991 27,568
Invested Capital Turnover
0.41 0.46 0.45 0.44 0.43 0.43 0.42 0.43 0.42 0.44 0.45
Increase / (Decrease) in Invested Capital
-6,773 -498 -450 -985 821 512 -39 616 -146 -660 -787
Enterprise Value (EV)
34,261 35,601 35,020 34,900 39,723 36,825 37,589 38,629 42,047 36,546 35,990
Market Capitalization
24,380 32,783 32,077 32,148 33,571 32,453 32,818 33,653 37,203 31,869 31,220
Book Value per Share
$49.73 $53.48 $58.33 $56.91 $52.70 $56.46 $55.78 $55.81 $57.99 $55.87 $54.62
Tangible Book Value per Share
$6.10 $8.88 $10.18 $9.35 $1.97 $4.06 $3.15 $3.11 $4.23 $3.38 $3.91
Total Capital
37,354 35,091 35,268 34,628 32,842 32,525 31,788 30,932 31,827 30,964 30,442
Total Debt
11,851 8,074 8,107 8,075 8,215 7,800 7,776 7,168 7,170 7,171 7,174
Total Long-Term Debt
10,564 7,774 7,807 7,775 7,740 7,800 7,776 7,168 7,170 5,323 5,325
Net Debt
9,287 2,370 2,519 2,322 5,717 3,926 4,343 4,547 4,399 4,234 4,336
Capital Expenditures (CapEx)
155 160 232 123 119 145 207 102 109 161 249
Debt-free, Cash-free Net Working Capital (DFCFNWC)
7,838 2,866 3,250 2,692 2,975 1,613 1,688 1,868 1,963 1,555 1,914
Debt-free Net Working Capital (DFNWC)
9,623 7,837 8,094 7,688 4,722 4,416 4,035 3,377 3,614 3,411 3,681
Net Working Capital (NWC)
8,336 7,537 7,794 7,388 4,247 4,416 4,035 3,377 3,614 1,563 1,832
Net Nonoperating Expense (NNE)
45 -4,111 47 428 -11 -347 18 88 -85 -379 270
Net Nonoperating Obligations (NNO)
2,843 1,122 1,233 1,142 4,540 3,926 4,343 4,547 4,364 4,198 4,300
Total Depreciation and Amortization (D&A)
283 274 277 282 294 294 291 298 306 299 293
Debt-free, Cash-free Net Working Capital to Revenue
59.56% 22.02% 25.47% 21.48% 24.24% 13.37% 14.09% 15.49% 16.10% 12.55% 15.29%
Debt-free Net Working Capital to Revenue
73.13% 60.21% 63.43% 61.34% 38.47% 36.59% 33.68% 28.01% 29.64% 27.54% 29.40%
Net Working Capital to Revenue
63.35% 57.90% 61.08% 58.95% 34.60% 36.59% 33.68% 28.01% 29.64% 12.62% 14.63%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.73 $8.53 $0.56 ($0.29) $0.71 ($0.04) $0.45 $0.43 $1.09 ($0.29) ($1.41)
Adjusted Weighted Average Basic Shares Outstanding
499.40M 498.50M 458.80M 459.20M 451.70M 449.90M 422.80M 417.80M 417.90M 419.20M 418.50M
Adjusted Diluted Earnings per Share
$0.73 $8.52 $0.56 ($0.28) $0.70 ($0.04) $0.45 $0.42 $1.08 ($0.28) ($1.41)
Adjusted Weighted Average Diluted Shares Outstanding
500.40M 499.40M 460.20M 460.30M 453.40M 451.20M 424.30M 419.30M 419.50M 420.60M 418.50M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
496.79M 458.34M 459.02M 459.06M 430.04M 417.58M 418.10M 417.50M 417.96M 418.05M 418.50M
Normalized Net Operating Profit after Tax (NOPAT)
421 262 323 324 322 -272 241 278 394 370 258
Normalized NOPAT Margin
12.69% 8.43% 10.70% 10.48% 10.54% -9.40% 8.23% 8.76% 12.34% 11.98% 8.42%
Pre Tax Income Margin
15.01% 6.22% 11.80% 11.51% 13.34% -21.26% 9.11% 9.33% 18.36% 1.39% -13.99%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
4.77 2.48 4.59 4.49 4.89 -5.21 3.66 3.76 7.57 1.38 -4.16
NOPAT to Interest Expense
3.29 1.04 3.29 3.18 3.10 -3.58 2.23 2.76 4.33 -5.78 -3.76
EBIT Less CapEx to Interest Expense
3.55 1.16 2.15 3.23 3.73 -6.64 1.50 2.73 6.32 -0.54 -7.16
NOPAT Less CapEx to Interest Expense
2.08 -0.27 0.84 1.92 1.94 -5.01 0.08 1.73 3.08 -7.69 -6.76
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
35.49% 11.46% 12.16% 14.53% 14.43% 148.92% 169.54% 94.97% 79.40% 89.57% -1,648.78%
Augmented Payout Ratio
35.49% 11.46% 12.16% 14.53% 14.43% 148.92% 169.54% 94.97% 79.40% 89.57% -1,648.78%

Frequently Asked Questions About DowDuPont's Financials

When does DowDuPont's financial year end?

According to the most recent income statement we have on file, DowDuPont's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has DowDuPont's net income changed over the last 9 years?

DowDuPont's net income appears to be on a downward trend, with a most recent value of $738 million in 2024, falling from $7.78 billion in 2015. The previous period was $462 million in 2023.

What is DowDuPont's operating income?
DowDuPont's total operating income in 2024 was $1.57 billion, based on the following breakdown:
  • Total Gross Profit: $4.51 billion
  • Total Operating Expenses: $2.93 billion
How has DowDuPont revenue changed over the last 9 years?

Over the last 9 years, DowDuPont's total revenue changed from $48.78 billion in 2015 to $12.39 billion in 2024, a change of -74.6%.

How much debt does DowDuPont have?

DowDuPont's total liabilities were at $12.84 billion at the end of 2024, a 7.1% decrease from 2023, and a 75.4% decrease since 2016.

How much cash does DowDuPont have?

In the past 8 years, DowDuPont's cash and equivalents has ranged from $1.54 billion in 2019 to $13.44 billion in 2017, and is currently $1.85 billion as of their latest financial filing in 2024.

How has DowDuPont's book value per share changed over the last 9 years?

Over the last 9 years, DowDuPont's book value per share changed from 0.00 in 2015 to 55.87 in 2024, a change of 5,586.7%.



This page (NYSE:DWDP) was last updated on 5/12/2025 by MarketBeat.com Staff
From Our Partners